Dr Woolhouse undertook undergraduate medical training at the University of Newcastle-upon-Tyne then moved to the West Midlands to complete his training in respiratory medicine.
He completed an MD thesis on pulmonary leukocyte recruitment at the University of Birmingham. Dr Woolhouse went on to lead the lung cancer service at University Hospitals Birmingham and was responsible for implanting innovative new pathways including straight-to-CT and endobronchial ultrasound.
At a national level, Dr Woolhouse led the National Lung Cancer Audit and Improving Outcomes project then moved to the role of clinical director of the audit and accreditation department at the Royal College of Physicians.
He was also seconded to the health service quality improvement partnership to lead on a health foundation funded improvement programme.
Lung cancer and mesothelioma pathways, patient experience and clinical quality improvement.
Impact of clinical and organisational factors on lung cancer outcomes.
- MBBS University of Newcastle-upon-Tyne
- MD University of Birmingham
- PGcertMedEd University of Wolverhampton
- Member of the Royal College of Physicians (London)
Woolhouse I, Bishop L, Darlison L, de Fonseka D, Edey A, Edwards J, Faivre-Finn C, Fennell DA, Holmes S, Kerr KM, Nakas A, Peel T, Rahman NM, Slade M, Steele J, Tsim S, Maskell NA. BTS guideline for the investigation and management of malignant pleural mesothelioma. BMJ Open Respir Res. 2018 Feb 14;5(1)
Baldwin D, Callister M, Akram A, Cane P, Draffan J, Franks K, Gleeson F, Graham R, Malhotra P, Pearson P, Subesinghe M, Waller D, Woolhouse I. British Thoracic Society quality standards for the investigation and management of pulmonary nodules. BMJ Open Respir Res. 2018 Apr 16;5(1):e000273.
Adizie JB, Khakwani A, Beckett P, Hubbard R, Navani N, Harden SV, Woolhouse I. Impact of organisation and specialist service delivery on lung cancer outcomes. Thorax. 2019 Jun;74(6):546-550. doi: 10.1136/thoraxjnl-2018-212588.
Adizie JB, Khakwani A, Beckett P, Navani N, West D, Woolhouse I, Harden SV. Stage III Non-small Cell Lung Cancer Management in England. Clin Oncol (R Coll Radiol). 2019 Oct;31(10):688-696
Perrotta F, Nankivell M, Adizie JB, Maqsood U, Elshafi M, Jafri S, Lerner AD, Woolhouse I, Munavvar M, Evison M, Booton R, Baldwin DR, Janes SM, Kerr KM, Bianco A, Yarmus L, Navani N. Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration for PD-L1 Testing in Non-small Cell Lung Cancer. Chest. 2020 Sep;158(3):1230-1239.
Craig C, Johnston J, Goodley P, Bishop P, Al-Najjar H, Brown L, Gallagher J, Sundar R, Upperton S, Callister M, Meek D, Succony L, Parvez W, Tufail M, Jayasekera G, Maclay J, Livesey A, Woolhouse I, Smith N, Bibby A, Evison M. What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study. JTO Clin Res Rep. 2024 May 30;5(8)
